Short-term outcomes of 47 selective laparoscopic lymph node dissection for rectal cancer: A retrospective study

Xiajuan Xue,Shuijie Lin,Qunzhang Zeng,Yincong Guo
DOI: https://doi.org/10.1097/md.0000000000039684
IF: 1.6
2024-10-30
Medicine
Abstract:For low rectal cancer, lymphatic drainage to the iliac vascular system is theoretically present. A retrospective study in Japan showed an overall lateral lymph node metastasis rate of 13.9% for rectal cancer. Moreover, lateral lymph node dissection (LLND) could reduce local recurrence by 50.3% and improve 5-year survival by 8% for T3/T4 rectal cancer below peritoneal recursion. [ 1 ] However, LLND significantly prolonged operative time and bleeding and increased autonomic nerve injury. [ 2 ] In the past 30 years, as preoperative neoadjuvant chemoradiotherapy and total mesorectal excision (TME) surgery have become the standard treatment mode for low-advanced rectal cancer, local recurrence has been well controlled. Therefore, prophylactic lateral lymph node dissection is highly controversial for radical resection of rectal cancer. [ 3 ] Whether or not neoadjuvant therapy is received, the presence of suspected lateral metastatic lymph nodes on preoperative imaging is a high-risk factor for postoperative local recurrence. [ 4–6 ] Other studies found that 20% of patients with LLND surgery after preoperative radiotherapy and chemotherapy have performed lateral lymph node pathology positive. [ 5–8 ] Despite the lack of data support, selective LLND for low rectal cancer is gradually gaining acceptance. [ 9 ]
medicine, general & internal
What problem does this paper attempt to address?